跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Norbipine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Norbipine
Approved
STANDARD
Norbipine
Ubi Pharma Inc. (Hsinchu Plant)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cb7e8f38b4a1b045
Company
Ubi Pharma Inc. (Hsinchu Plant)
Type
Standard
Approval Details
Approval Id
cb7e8f38b4a1b045
Drug Approval Philippines Name
Norbipine
Product Name
Norbipine
Registration Number
DRP-12718
Brand Name
Norbipine
Generic Name
Norepinephrine (As Bitartrate)
Dosage Form
Solution for I.V. Infusion
Dosage Strength
1 mg/mL (4 mg/4 mL)
Manufacturer
Ubi Pharma Inc. (Hsinchu Plant)
Importer
Neo-Care Philippines
Distributor
Neo-Care Philippines
Issuance Date
28 September 2022
Expiry Date
28 September 2025
Pharmacologic Category
Adrenergic and dopaminergic agent
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cb7e8f38b4a1b045
Type
Standard
Back to Philippines FDA Approvals